Literature DB >> 23479033

Relationship of cognitive performance with prolidase and oxidative stress in Alzheimer disease.

Adalet Arikanoglu1, Esref Akil, Sefer Varol, Yavuz Yucel, Hatice Yuksel, Mehmet Ugur Cevik, Yilmaz Palanci, Fatma Unan.   

Abstract

Glutamate excitotoxicity and oxidative stress are held responsible for the pathogenesis of Alzheimer's disease (AD). Prolidase is known to have a crucial part in the recycling of proline for collagen synthesis. Elevated proline levels have been shown to increase glutamate concentration. To our knowledge, prolidase activity in AD has not yet been studied. In this study, we aimed to reveal the relationship of AD with oxidative stress and collagen turnover by comparing AD patients and healthy control group with regard to total antioxidant status (TAS), total oxidant status (TOS), and prolidase levels. Fifty patients (mean age, 72.5 ± 8.9 years) diagnosed with AD and a control group comprised of 39 healthy individuals (mean age, 69.1 ± 7.1 years) were compared relative to serum TAS, TOS, and prolidase levels. The relationship of cognitive performance with prolidase, TAS, and TOS was evaluated by Mini mental state examination (MMSE). Alzheimer's disease group demonstrated statistically significantly higher prolidase and TOS levels as compared to the control group (p = 0.01, p = 0.018, respectively). Total antioxidant status level was significantly lower in the dementia group than in the control group (p = 0.032). MMSE manifested a negative correlation with prolidase and TOS levels (p = 0.001, r = -0.33; p = 0.002, r = -0.32, respectively), while displaying a positive correlation with TAS levels (p = 0.002, r = 0.32). In conclusion, elevated prolidase and TOS levels along with reduced TAS concentrations suggest that oxidative stress and collagen breakdown are involved in the cognitive impairment in AD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23479033     DOI: 10.1007/s10072-013-1346-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  26 in total

1.  Plasma oxidative stress parameters in men and women with early stage Alzheimer type dementia.

Authors:  M C Puertas; J M Martínez-Martos; M P Cobo; M P Carrera; M D Mayas; M J Ramírez-Expósito
Journal:  Exp Gerontol       Date:  2012-06-01       Impact factor: 4.032

Review 2.  The glutamate synapse in neuropsychiatric disorders. Focus on schizophrenia and Alzheimer's disease.

Authors:  N B Farber; J W Newcomer; J W Olney
Journal:  Prog Brain Res       Date:  1998       Impact factor: 2.453

3.  A new automated colorimetric method for measuring total oxidant status.

Authors:  Ozcan Erel
Journal:  Clin Biochem       Date:  2005-10-07       Impact factor: 3.281

Review 4.  Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease.

Authors:  R J Mark; E M Blanc; M P Mattson
Journal:  Mol Neurobiol       Date:  1996-06       Impact factor: 5.590

5.  Prolidase activity dysregulation and its correlation with oxidative-antioxidative status in chronic obstructive pulmonary disease.

Authors:  Mehmet Gencer; Nurten Aksoy; E Canan Dagli; Elmas Uzer; Sahin Aksoy; Sahbettin Selek; Hakim Celik; Hale Cakir
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

Review 6.  Environmental-induced oxidative stress in neurodegenerative disorders and aging.

Authors:  Lucia Migliore; Fabio Coppedè
Journal:  Mutat Res       Date:  2008-10-05       Impact factor: 2.433

Review 7.  Oxidative alterations in Alzheimer's disease.

Authors:  W R Markesbery; J M Carney
Journal:  Brain Pathol       Date:  1999-01       Impact factor: 6.508

Review 8.  Oxidative stress signalling in Alzheimer's disease.

Authors:  Xiongwei Zhu; Arun K Raina; Hyoung-Gon Lee; Gemma Casadesus; Mark A Smith; George Perry
Journal:  Brain Res       Date:  2004-03-12       Impact factor: 3.252

9.  Dietary intake of antioxidants and risk of Alzheimer disease.

Authors:  Marianne J Engelhart; Mirjam I Geerlings; Annemieke Ruitenberg; John C van Swieten; Albert Hofman; Jacqueline C M Witteman; Monique M B Breteler
Journal:  JAMA       Date:  2002-06-26       Impact factor: 56.272

10.  Prolidase deficiency: biochemical study of erythrocyte and skin fibroblast prolidase activity in Italian patients.

Authors:  G Zanaboni; K M Dyne; A Rossi; V Monafo; G Cetta
Journal:  Haematologica       Date:  1994 Jan-Feb       Impact factor: 9.941

View more
  9 in total

1.  Tocotrienol prevents AAPH-induced neurite degeneration in neuro2a cells.

Authors:  Koji Fukui; Hidekazu Sekiguchi; Hirokatsu Takatsu; Taisuke Koike; Tatsuro Koike; Shiro Urano
Journal:  Redox Rep       Date:  2013       Impact factor: 4.412

2.  Edaravone injection ameliorates cognitive deficits in rat model of Alzheimer's disease.

Authors:  Rui Yang; Qingjun Wang; Fang Li; Jian Li; Xuewen Liu
Journal:  Neurol Sci       Date:  2015-07-12       Impact factor: 3.307

3.  Altered lipid peroxidation markers are related to post-traumatic stress disorder (PTSD) and not trauma itself in earthquake survivors.

Authors:  Abdullah Atli; Mahmut Bulut; Yasin Bez; İbrahim Kaplan; Pınar Güzel Özdemir; Cem Uysal; Hilal Selçuk; Aytekin Sir
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-09-01       Impact factor: 5.270

4.  Serum Prolidase Enzyme Activity Level: Not a Predictive Biomarker for Epilepsy.

Authors:  Zeynep Ozozen Ayas; Dilcan Kotan; Mehmet Akdogan; Mustafa Ercan Gunel
Journal:  Eurasian J Med       Date:  2018-11-30

5.  Decreased Prolidase Activity in Patients with Posttraumatic Stress Disorder.

Authors:  Süleyman Demir; Mahmut Bulut; Abdullah Atli; İbrahim Kaplan; Mehmet Cemal Kaya; Yasin Bez; Pınar Güzel Özdemir; Aytekin Sır
Journal:  Psychiatry Investig       Date:  2016-07-25       Impact factor: 2.505

6.  A Novel Role of Prolidase in Cocaine-Mediated Breach in the Barrier of Brain Microvascular Endothelial Cells.

Authors:  Binah Baht Ysrayl; Muthukumar Balasubramaniam; Ife Albert; Fernando Villalta; Jui Pandhare; Chandravanu Dash
Journal:  Sci Rep       Date:  2019-02-22       Impact factor: 4.379

7.  Plasma Prolidase Activity and Oxidative Stress in Patients with Parkinson's Disease.

Authors:  Akhilesh Kumar Verma; Janak Raj; Vivek Sharma; Tej Bali Singh; Shalabh Srivastava; Ragini Srivastava
Journal:  Parkinsons Dis       Date:  2015-08-09

8.  Neuroinflammation and related neuropathologies in APPSL mice: further value of this in vivo model of Alzheimer's disease.

Authors:  Tina Löffler; Stefanie Flunkert; Daniel Havas; Cornelia Schweinzer; Marni Uger; Manfred Windisch; Ernst Steyrer; Birgit Hutter-Paier
Journal:  J Neuroinflammation       Date:  2014-05-01       Impact factor: 8.322

9.  Comparison of Selected Parameters of Redox Homeostasis in Patients with Ataxia-Telangiectasia and Nijmegen Breakage Syndrome.

Authors:  Barbara Pietrucha; Edyta Heropolitanska-Pliszka; Mateusz Maciejczyk; Halina Car; Jolanta Sawicka-Powierza; Radosław Motkowski; Joanna Karpinska; Marta Hryniewicka; Anna Zalewska; Malgorzata Pac; Beata Wolska-Kusnierz; Ewa Bernatowska; Bozena Mikoluc
Journal:  Oxid Med Cell Longev       Date:  2017-12-31       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.